SARCOIDOSIS DIAGNOSED IN THE ELDERLY: A CASE CONTROL STUDY. En savoir plus sur SARCOIDOSIS DIAGNOSED IN THE ELDERLY: A CASE CONTROL STUDY.
Craniofacial bone alterations in patients with neurofibromatosis type 1. En savoir plus sur Craniofacial bone alterations in patients with neurofibromatosis type 1.
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. En savoir plus sur Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer. En savoir plus sur Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer.
Connected Surveillance for Detection of Complications After Early Discharge from Bariatric Surgery. En savoir plus sur Connected Surveillance for Detection of Complications After Early Discharge from Bariatric Surgery.
Let''s Avoid Opioids in Aesthetic Surgery. En savoir plus sur Let''s Avoid Opioids in Aesthetic Surgery.
Editorial Commentary: Trochleoplasty: Is It Really That Fearsome and Dangerous a Technique? En savoir plus sur Editorial Commentary: Trochleoplasty: Is It Really That Fearsome and Dangerous a Technique?
Creation of a specialist core curriculum for the European Society for Sports traumatology, Knee surgery and Arthroscopy (ESSKA). En savoir plus sur Creation of a specialist core curriculum for the European Society for Sports traumatology, Knee surgery and Arthroscopy (ESSKA).
[SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic]. En savoir plus sur [SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic].
Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry. En savoir plus sur Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry.